Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli
出版年份 2011 全文链接
标题
Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli
作者
关键词
-
出版物
JOURNAL OF CELLULAR PHYSIOLOGY
Volume 227, Issue 4, Pages 1319-1325
出版商
Wiley
发表日期
2011-05-20
DOI
10.1002/jcp.22843
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma
- (2011) Wei-Tien Tai et al. JOURNAL OF HEPATOLOGY
- Hepatocellular Carcinoma: Novel Molecular Approaches for Diagnosis, Prognosis, and Therapy
- (2010) Augusto Villanueva et al. Annual Review of Medicine
- Induction of DNA Damage-Inducible Gene GADD45 Contributes to Sorafenib-Induced Apoptosis in Hepatocellular Carcinoma Cells
- (2010) D.-L. Ou et al. CANCER RESEARCH
- Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression
- (2010) Eek Joong Park et al. CELL
- Development of Molecularly Targeted Therapies in Hepatocellular Carcinoma: Where Do We Go Now?
- (2010) R. S. Finn CLINICAL CANCER RESEARCH
- Sorafenib Overcomes TRAIL Resistance of Hepatocellular Carcinoma Cells through the Inhibition of STAT3
- (2010) K.-F. Chen et al. CLINICAL CANCER RESEARCH
- Novel inhibitors in development for hepatocellular carcinoma
- (2010) Marcus Alexander Wörns et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The Bcl-xL inhibitor, ABT-737, efficiently induces apoptosis and suppresses growth of hepatoma cells in combination with sorafenib
- (2010) Hayato Hikita et al. HEPATOLOGY
- Gene signatures in hepatocellular carcinoma (HCC)
- (2010) Ourania M. Andrisani et al. SEMINARS IN CANCER BIOLOGY
- Sorafenib Induces Apoptosis Specifically in Cells Expressing BCR/ABL by Inhibiting Its Kinase Activity to Activate the Intrinsic Mitochondrial Pathway
- (2009) T. Kurosu et al. CANCER RESEARCH
- Overactivation of the MEK/ERK Pathway in Liver Tumor Cells Confers Resistance to TGF- -Induced Cell Death through Impairing Up-regulation of the NADPH Oxidase NOX4
- (2009) L. Caja et al. CANCER RESEARCH
- Induction of Bim Expression Contributes to the Antitumor Synergy Between Sorafenib and Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase Inhibitor CI-1040 in Hepatocellular Carcinoma
- (2009) D.-L. Ou et al. CLINICAL CANCER RESEARCH
- Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2
- (2009) Boris R. A. Blechacz et al. HEPATOLOGY
- JNK1-dependent PUMA Expression Contributes to Hepatocyte Lipoapoptosis
- (2009) Sophie C. Cazanave et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines
- (2009) Paola Ulivi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo
- (2009) Pippa Newell et al. JOURNAL OF HEPATOLOGY
- AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)
- (2009) Hung Huynh et al. JOURNAL OF HEPATOLOGY
- PUMA, a potent killer with or without p53
- (2009) J Yu et al. ONCOGENE
- PUMA mediates EGFR tyrosine kinase inhibitor-induced apoptosis in head and neck cancer cells
- (2009) Q Sun et al. ONCOGENE
- Dysregulation of apoptosis in hepatocellular carcinoma cells
- (2009) Isabel Fabregat WORLD JOURNAL OF GASTROENTEROLOGY
- Inhibition of the EGF receptor blocks autocrine growth and increases the cytotoxic effects of doxorubicin in rat hepatoma cells
- (2008) Conrad Ortiz et al. BIOCHEMICAL PHARMACOLOGY
- Vorinostat and Sorafenib Synergistically Kill Tumor Cells via FLIP Suppression and CD95 Activation
- (2008) G. Zhang et al. CLINICAL CANCER RESEARCH
- Sorafenib induces apoptosis of AML cells via Bim-mediated activation of the intrinsic apoptotic pathway
- (2008) W Zhang et al. LEUKEMIA
- Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
- (2008) Scott M. Wilhelm et al. MOLECULAR CANCER THERAPEUTICS
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More